Literature DB >> 27128386

Ubiquitin-Specific Protease 4 Antagonizes Osteoblast Differentiation Through Dishevelled.

Fangfang Zhou1,2,3, Fang Li4, Pengfei Fang4, Tong Dai5, Bing Yang6, Hans van Dam7, Junling Jia4, Min Zheng8, Long Zhang9.   

Abstract

The canonical Wnt/β-catenin signaling pathway plays a pivotal role and is essentially required for the osteoblast differentiation and bone formation. In this study, we found ubiquitin-specific peptidase 4 (USP4) to strongly inhibit the Wnt/β-catenin signaling by removing Lysine-63 linked poly-ubiquitin chain from Dishevelled (Dvl). Ectopic expression of USP4 promoted β-catenin poly-ubiquitination and thus inhibited Wnt-induced accumulation of cytosolic β-catenin and counteracted Wnt-induced transcriptional activity. Moreover, USP4 knockdown or USP4 knockout led to an increase in the active β-catenin levels and in activation of Wnt/β-catenin-induced transcription. Functional studies in C2C12 myoblasts and KS483 osteoprogenitor cells showed that ectopic expression of USP4 resulted in impaired activation of endogenous Wnt3a-induced genes and decreased osteoblast differentiation and mineralization, whereas USP4 depletion showed the opposite effect. These results identify USP4 as a novel regulator of Dvl in Wnt/β-catenin signal and show its involvement in Wnt3a-induced osteoblast differentiation.
© 2016 American Society for Bone and Mineral Research. © 2016 American Society for Bone and Mineral Research.

Entities:  

Keywords:  DISHEVELLED; OSTEOBLAST DIFFERENTIATION; UBIQUITINATION; USP4; Wnt3a; β-CATENIN

Mesh:

Substances:

Year:  2016        PMID: 27128386     DOI: 10.1002/jbmr.2863

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Ubiquitin-specific protease USP34 controls osteogenic differentiation and bone formation by regulating BMP2 signaling.

Authors:  Yu-Chen Guo; Meng-Yuan Wang; Shi-Wen Zhang; Yun-Shu Wu; Chen-Chen Zhou; Ri-Xin Zheng; Bin Shao; Yuan Wang; Liang Xie; Wei-Qing Liu; Ning-Yuan Sun; Jun-Jun Jing; Ling Ye; Qian-Ming Chen; Quan Yuan
Journal:  EMBO J       Date:  2018-09-04       Impact factor: 11.598

2.  Ixazomib enhances parathyroid hormone-induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor.

Authors:  Yanmei Yang; Hong Lei; Ya-Wei Qiang; Bin Wang
Journal:  Mol Biol Cell       Date:  2017-05-11       Impact factor: 4.138

Review 3.  Deubiquitinating Enzymes and Bone Remodeling.

Authors:  Yu-Chen Guo; Shi-Wen Zhang; Quan Yuan
Journal:  Stem Cells Int       Date:  2018-07-08       Impact factor: 5.443

4.  Deubiquitinating Enzyme USP8 Is Essential for Skeletogenesis by Regulating Wnt Signaling.

Authors:  Sachin Chaugule; Jung-Min Kim; Yeon-Suk Yang; Klaus-Peter Knobeloch; Xi He; Jae-Hyuck Shim
Journal:  Int J Mol Sci       Date:  2021-09-24       Impact factor: 5.923

5.  USP25 Expression in Peripheral Blood Mononuclear Cells Is Associated With Bone Mineral Density in Women.

Authors:  Jianlin Shen; Bowen Fu; Yanjiao Wu; Yang Yang; Xiaoning Lin; Haibin Lin; Huan Liu; Wenhua Huang
Journal:  Front Cell Dev Biol       Date:  2022-01-24

6.  The osteoprotective role of USP26 in coordinating bone formation and resorption.

Authors:  Changwei Li; Minglong Qiu; Leilei Chang; Jin Qi; Lianfang Zhang; Bernhard Ryffel; Lianfu Deng
Journal:  Cell Death Differ       Date:  2022-01-29       Impact factor: 12.067

7.  Genome-Wide CRISPR/Cas9-Based Screening for Deubiquitinase Subfamily Identifies Ubiquitin-Specific Protease 11 as a Novel Regulator of Osteogenic Differentiation.

Authors:  Kamini Kaushal; Apoorvi Tyagi; Janardhan Keshav Karapurkar; Eun-Jung Kim; Parthasaradhireddy Tanguturi; Kye-Seong Kim; Han-Sung Jung; Suresh Ramakrishna
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.